PlainVisa
2026 data Public-data reference Official source

Catalent Pharma Solutions

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
223
DOL-certified
94.2%
Median offered wage
$108,218

Tampa, NJ NAICS: 54171

How many H-1B LCA filings list Catalent Pharma Solutions?

U.S. Department of Labor's OFLC discloses 223 Labor Condition Application filings naming Catalent Pharma Solutions from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for Catalent Pharma Solutions?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 328 H-1B petitions naming Catalent Pharma Solutions through FY2024, and approved the large majority of them: 96.3% approved (316 approvals, 12 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Catalent Pharma Solutions is listed in 223 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 94.2% of those LCAs; the median listed offered wage is $108,218. This is not a USCIS approval, hiring, or sponsorship ranking.

223
DOL LCA filings, FY2023–FY2026
94.2%
DOL-certified
$108,218
median offered wage
Top 1%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Tampa, NJ.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Catalent Pharma Solutions vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

223 1036th of 122824 higher than 121,788 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · Catalent Pharma Solutions

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $53,040$450,000 .

Title concentration

  • Technician, Biomanufacturing, Downstream/mRNA 13 · 5.8% · $54,080
  • Manufacturing Technical Operations Specialist 12 · 5.4% · $107,333
  • Process Engineer 6 · 2.7% · $97,106
  • Sr. Specialist, Quality Assurance Batch Disposition 5 · 2.2% · $108,841
  • Development Scientist 5 · 2.2% · $91,083

Worksite counties

  • ANNE ARUNDEL, MD 29 · 36.3%
  • DANE, WI 25 · 31.3%
  • CLARK, KY 7 · 8.8%
  • PINELLAS, FL 4 · 5%
  • PITT, NC 3 · 3.8%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • Catalent Pharma Solutions's disclosed H-1B LCA filing count rose from 60 in FY2024 to 82 in FY2025 (+36.7%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

National-scale filing footprint

Catalent Pharma Solutions has filed 223 LCAs (more volume than 99% of U.S. employer filers in this extract). DOL certification: 94.2%. Worksites span 11 states , led by MD.

Above-prevailing wage posture

On 222 LCAs with comparable offered vs prevailing wages, Catalent Pharma Solutions averages about 18.5% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (34.1% of LCA filings).

Certification Rate

94.2%

Moderate DOL cert

Avg. Salary

$108,218

Near portal avg

Total Workers

223

Moderate worker count

Compare with another employer filer

Catalent Pharma Solutions vs a peer vs the national average, from DOL LCA data.

Avg. offered wage$108,218 · 28% lower than Ernst & Young US LLP
This filer
Peer
$149,512
National avg.
$113,357
Certification rate94.2% · 3% lower than Ernst & Young US LLP
This filer
Peer
97.6%
National avg.
97.7%
Total LCA filings223 · 99% lower than Ernst & Young US LLP
This filer
Peer
39,678
National avg.
17
FY2025 filings are 122% of FY2023

67 completed-year filings in FY2023, 82 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at Catalent Pharma Solutions

Minimum
$53,040
Maximum
$450,000
Average Salary
$108,218

LCA Filing History

H-1B LCA filing trends from FY2023 to FY2026

FY2023 67 LCA filings · 92.5% DOL-certified · $107,178 avg
FY2024 59 LCA filings · 91.5% DOL-certified · $104,728 avg
FY2025 82 LCA filings · 98.8% DOL-certified · $103,755 avg

FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).

Top Occupations

Most frequently listed job titles at Catalent Pharma Solutions

Job Title LCA filings Avg. Salary
Technician, Biomanufacturing, Downstream/mRNA 13 $54,080
Manufacturing Technical Operations Specialist 12 $107,333
Process Engineer 6 $97,106
Sr. Specialist, Quality Assurance Batch Disposition 5 $108,841
Development Scientist 5 $91,083
Sr. Associate, Biomanufacturing, Downstream/mRNA 4 $74,000
Senior Quality Assurance Specialist 4 $109,981
Scientist, Quality Control 4 $75,812
PAT Testing Engineer 4 $82,752
Engineer, MS&T 4 $78,883
Analytical Scientist, AR&D 4 $91,690
Technician, Biomanufacturing, Upstream 3 $53,733
Senior Scientist, Product Development 3 $117,667
Senior Analyst, Quality Assurance 3 $105,486
Principal Scientist, Product Development 3 $156,667

Geographic Distribution

Where Catalent Pharma Solutions places H-1B workers across the United States

MD 34 LCA filings
WI 32 LCA filings
FL 7 LCA filings
KY 7 LCA filings
CA 5 LCA filings
NC 5 LCA filings
MA 4 LCA filings
NJ 2 LCA filings
IN 2 LCA filings
PA 1 LCA filings
VA 1 LCA filings

Nationwide peers near Catalent Pharma Solutions's 223-LCA band

Cross-state DOL neighbors for Catalent Pharma Solutions - LCA filing-count and offered-wage axes, outside NJ.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (223 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($108,218 here).

Disclaimer: Informational only, not professional advice.

Read with Catalent Pharma Solutions

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-SOLID · WAGE-PAR.

What to do with this profile

Use the DOL LCA record for Catalent Pharma Solutions to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.